North America Overactive Bladder Treatment Market by Manufacturers, Countries, Type and Application, Forecast to 2022




Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). Scope of the Report: This report focuses on the Overactive Bladder Treatment in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Astellas Pharma Allergan Pfizer Teva (Activas) Johnson & Johnson Market Segment by Countries, covering United States Canada Mexico Market Segment by Type, covers Anticholinergics Mirabegron Botox Market Segment by Applications, can be divided into Idiopathic Overactive Bladder Neurogenic Overactive Bladder There are 15 Chapters to deeply display the North America Overactive Bladder Treatment market. Chapter 1, to describe Overactive Bladder Treatment Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Overactive Bladder Treatment, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Overactive Bladder Treatment, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications; Chapter 10, Overactive Bladder Treatment market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022; Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 13, to describe sales channel, distributors, traders, dealers etc. Chapter 14 and 15, to describe Overactive Bladder Treatment Research Findings and Conclusion, Appendix, methodology and data source


Table of Contents
1 Market Overview
    1.1 Overactive Bladder Treatment Introduction
    1.2 Market Analysis by Type
        1.2.1 Anticholinergics
        1.2.2 Mirabegron
        1.2.3 Botox
    1.3 Market Analysis by Applications
        1.3.1 Idiopathic Overactive Bladder
        1.3.2 Neurogenic Overactive Bladder
    1.4 Market Analysis by Countries
        1.4.1 United States Status and Prospect (2012-2022)
        1.4.2 Mexico Status and Prospect (2012-2022)
        1.4.3 Canada Status and Prospect (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Astellas Pharma
        2.1.1 Profile
        2.1.2 Overactive Bladder Treatment Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 Astellas Pharma Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.1.4 Business Overview
        2.1.5 Astellas Pharma News
    2.2 Allergan
        2.2.1 Profile
        2.2.2 Overactive Bladder Treatment Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Allergan Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.2.4 Business Overview
        2.2.5 Allergan News
    2.3 Pfizer
        2.3.1 Profile
        2.3.2 Overactive Bladder Treatment Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Pfizer Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.3.4 Business Overview
        2.3.5 Pfizer News
    2.4 Teva (Activas)
        2.4.1 Profile
        2.4.2 Overactive Bladder Treatment Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 Teva (Activas) Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.4.4 Business Overview
        2.4.5 Teva (Activas) News
    2.5 Johnson & Johnson
        2.5.1 Profile
        2.5.2 Overactive Bladder Treatment Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 Johnson & Johnson Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.5.4 Business Overview
        2.5.5 Johnson & Johnson News
3 North America Overactive Bladder Treatment Market Competition, by Manufacturer
    3.1 North America Overactive Bladder Treatment Sales and Market Share by Manufacturer (2016-2017)
    3.2 North America Overactive Bladder Treatment Revenue and Market Share by Manufacturer (2016-2017)
    3.3 North America Overactive Bladder Treatment Price by Manufacturers (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Overactive Bladder Treatment Manufacturer Market Share
        3.4.2 Top 5 Overactive Bladder Treatment Manufacturer Market Share
    3.5 Market Competition Trend
4 North America Overactive Bladder Treatment Market Analysis by Countries
    4.1 North America Overactive Bladder Treatment Sales Market Share by Countries
    4.2 North America Overactive Bladder Treatment Sales by Countries (2012-2017)
    4.3 North America Overactive Bladder Treatment Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Overactive Bladder Treatment by Type
    5.1 North America Overactive Bladder Treatment Sales, Revenue and Market Share by Type (2012-2017)
        5.1.1 North America Overactive Bladder Treatment Sales and Market Share by Type (2012-2017)
        5.1.2 North America Overactive Bladder Treatment Revenue and Market Share by Type (2012-2017)
    5.2 Anticholinergics Sales Growth and Price
        5.2.1 North America Anticholinergics Sales Growth (2012-2017)
        5.2.2 North America Anticholinergics Price (2012-2017)
    5.3 Mirabegron Sales Growth and Price
        5.3.1 North America Mirabegron Sales Growth (2012-2017)
        5.3.2 North America Mirabegron Price (2012-2017)
    5.4 Botox Sales Growth and Price
        5.4.1 North America Botox Sales Growth (2012-2017)
        5.4.2 North America Botox Price (2012-2017)
6 North America Market Segmentation Overactive Bladder Treatment by Application
    6.1 North America Overactive Bladder Treatment Sales Market Share by Application (2012-2017)
    6.2 Idiopathic Overactive Bladder Sales Growth (2012-2017)
    6.3 Neurogenic Overactive Bladder Sales Growth (2012-2017)
7 United States Overactive Bladder Treatment Sales, Revenue, by Type, Application and Manufacturers
    7.1 United States Overactive Bladder Treatment Revenue, Sales and Growth Rate (2012-2017)
    7.2 United States Overactive Bladder Treatment Sales and Market Share by Type
    7.3 United States Overactive Bladder Treatment Sales by Application (2012-2017)
    7.4 United States Overactive Bladder Treatment Sales, Revenue and Market Share by Manufacturer
        7.4.1 United States Overactive Bladder Treatment Sales and Market Share by Manufacturer
        7.4.2 United States Overactive Bladder Treatment Revenue and Market Share by Manufacturer
    7.5 United States Overactive Bladder Treatment Export and Import (2012-2017)
8 Canada Overactive Bladder Treatment Sales, Revenue, by Type, Application and Manufacturers
    8.1 Canada Overactive Bladder Treatment Revenue, Sales and Growth Rate (2012-2017)
    8.2 Canada Overactive Bladder Treatment Sales and Market Share by Type
    8.3 Canada Overactive Bladder Treatment Sales by Application (2012-2017)
    8.4 Canada Overactive Bladder Treatment Sales, Revenue and Market Share by Manufacturer
        8.4.1 Canada Overactive Bladder Treatment Sales and Market Share by Manufacturer
        8.4.2 Canada Overactive Bladder Treatment Revenue and Market Share by Manufacturer
    8.5 Canada Overactive Bladder Treatment Export and Import (2012-2017)
9 Mexico Overactive Bladder Treatment Sales, Revenue, by Type, Application and Manufacturers
    9.1 Mexico Overactive Bladder Treatment Revenue, Sales and Growth Rate (2012-2017)
    9.2 Mexico Overactive Bladder Treatment Sales and Market Share by Type
    9.3 Mexico Overactive Bladder Treatment Sales by Application (2012-2017)
    9.4 Mexico Overactive Bladder Treatment Sales, Revenue and Market Share by Manufacturer
        9.4.1 Mexico Overactive Bladder Treatment Sales and Market Share by Manufacturer
        9.4.2 Mexico Overactive Bladder Treatment Revenue and Market Share by Manufacturer
    9.5 Mexico Overactive Bladder Treatment Export and Import (2012-2017)
10 Overactive Bladder Treatment Market Forecast (2017-2022)
    10.1 North America Overactive Bladder Treatment Sales, Revenue and Growth Rate (2017-2022)
    10.2 Overactive Bladder Treatment Market Forecast by Countries (2017-2022)
        10.2.1 United States Overactive Bladder Treatment Forecast (2017-2022)
        10.2.2 Canada Overactive Bladder Treatment Forecast (2017-2022)
        10.2.3 Mexico Overactive Bladder Treatment Forecast (2017-2022)
    10.3 Overactive Bladder Treatment Market Forecast by Type (2017-2022)
    10.4 Overactive Bladder Treatment Market Forecast by Application (2017-2022)
11 Overactive Bladder Treatment Manufacturing Cost Analysis
    11.1 Overactive Bladder Treatment Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Overactive Bladder Treatment
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Overactive Bladder Treatment Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Overactive Bladder Treatment Major Manufacturers in 2016
    12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Analyst Introduction
    15.3 Data Source
List of Tables and Figures

Figure Overactive Bladder Treatment Picture
Table Product Specifications of Overactive Bladder Treatment
Figure North America Sales Market Share of Overactive Bladder Treatment by Types in 2016
Table Types of Overactive Bladder Treatment
Figure Anticholinergics Picture
Table Major Manufacturers of Anticholinergics
Figure Mirabegron Picture
Table Major Manufacturers of Mirabegron
Figure Botox Picture
Table Major Manufacturers of Botox
Table North America Overactive Bladder Treatment Sales Market Share by Applications in 2016
Table Applications of Overactive Bladder Treatment
Figure Idiopathic Overactive Bladder Picture
Figure Neurogenic Overactive Bladder Picture
Figure United States Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Overactive Bladder Treatment Type and Applications
Table Astellas Pharma Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Overactive Bladder Treatment Type and Applications
Table Allergan Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Overactive Bladder Treatment Type and Applications
Table Pfizer Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva (Activas) Basic Information, Manufacturing Base and Competitors
Table Teva (Activas) Overactive Bladder Treatment Type and Applications
Table Teva (Activas) Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Overactive Bladder Treatment Type and Applications
Table Johnson & Johnson Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Overactive Bladder Treatment Sales by Manufacturer (2016-2017)
Figure North America Overactive Bladder Treatment Sales Market Share by Manufacturer in 2016
Figure North America Overactive Bladder Treatment Sales Market Share by Manufacturer in 2017
Table North America Overactive Bladder Treatment Revenue by Manufacturer (2016-2017)
Figure North America Overactive Bladder Treatment Revenue Market Share by Manufacturer in 2016
Figure North America Overactive Bladder Treatment Revenue Market Share by Manufacturer in 2017
Table North America Overactive Bladder Treatment Price by Manufacturers (2016-2017)
Figure Top 3 Overactive Bladder Treatment Manufacturer Market Share in 2016
Figure Top 3 Overactive Bladder Treatment Manufacturer Market Share in 2017
Figure Top 5 Overactive Bladder Treatment Manufacturer Market Share in 2016
Figure Top 5 Overactive Bladder Treatment Manufacturer Market Share in 2017
Figure North America Overactive Bladder Treatment Sales and Growth (2012-2017)
Table North America Overactive Bladder Treatment Sales by Countries (2012-2017)
Table North America Overactive Bladder Treatment Sales Market Share by Countries (2012-2017)
Figure North America 2012 Overactive Bladder Treatment Sales Market Share by Countries
Figure North America 2016 Overactive Bladder Treatment Sales Market Share by Countries
Figure North America Overactive Bladder Treatment Revenue and Growth (2012-2017)
Table North America Overactive Bladder Treatment Revenue by Countries (2012-2017)
Table North America Overactive Bladder Treatment Revenue Market Share by Countries (2012-2017)
Table North America 2012 Overactive Bladder Treatment Revenue Market Share by Countries
Table North America 2016 Overactive Bladder Treatment Revenue Market Share by Countries
Table North America Overactive Bladder Treatment Sales by Type (2012-2017)
Table North America Overactive Bladder Treatment Sales Share by Type (2012-2017)
Table North America Overactive Bladder Treatment Revenue by Type (2012-2017)
Table North America Overactive Bladder Treatment Revenue Share by Type (2012-2017)
Figure North America Anticholinergics Sales Growth (2012-2017)
Figure North America Anticholinergics Price (2012-2017)
Figure North America Mirabegron Sales Growth (2012-2017)
Figure North America Mirabegron Price (2012-2017)
Figure North America Botox Sales Growth (2012-2017)
Figure North America Botox Price (2012-2017)
Table North America Overactive Bladder Treatment Sales by Application (2012-2017)
Table North America Overactive Bladder Treatment Sales Share by Application (2012-2017)
Figure North America Idiopathic Overactive Bladder Sales Growth (2012-2017)
Figure North America Neurogenic Overactive Bladder Sales Growth (2012-2017)
Figure United States Overactive Bladder Treatment Revenue and Growth (2012-2017)
Figure United States Overactive Bladder Treatment Sales and Growth (2012-2017)
Table United States Overactive Bladder Treatment Sales by Type (2012-2017)
Table United States Overactive Bladder Treatment Sales Market Share by Type (2012-2017)
Table United States Overactive Bladder Treatment Sales by Application (2012-2017)
Table United States Overactive Bladder Treatment Sales Market Share by Application (2012-2017)
Table United States Overactive Bladder Treatment Sales by Manufacturer (2016-2017)
Figure United States Overactive Bladder Treatment Sales Market Share by Manufacturer in 2016
Figure United States Overactive Bladder Treatment Sales Market Share by Manufacturer in 2017
Table United States Overactive Bladder Treatment Revenue by Manufacturer (2016-2017)
Figure United States Overactive Bladder Treatment Revenue Market Share by Manufacturer in 2016
Figure United States Overactive Bladder Treatment Revenue Market Share by Manufacturer in 2017
Table United States Overactive Bladder Treatment Export and Import (2012-2017)
Figure Canada Overactive Bladder Treatment Revenue and Growth (2012-2017)
Figure Canada Overactive Bladder Treatment Sales and Growth (2012-2017)
Table Canada Overactive Bladder Treatment Sales by Type (2012-2017)
Table Canada Overactive Bladder Treatment Sales Market Share by Type (2012-2017)
Table Canada Overactive Bladder Treatment Sales by Application (2012-2017)
Table Canada Overactive Bladder Treatment Sales Market Share by Application (2012-2017)
Table Canada Overactive Bladder Treatment Sales by Manufacturer (2016-2017)
Figure Canada Overactive Bladder Treatment Sales Market Share by Manufacturer in 2016
Figure Canada Overactive Bladder Treatment Sales Market Share by Manufacturer in 2017
Table Canada Overactive Bladder Treatment Revenue by Manufacturer (2016-2017)
Figure Canada Overactive Bladder Treatment Revenue Market Share by Manufacturer in 2016
Figure Canada Overactive Bladder Treatment Revenue Market Share by Manufacturer in 2017
Table Canada Overactive Bladder Treatment Export and Import (2012-2017)
Figure Mexico Overactive Bladder Treatment Revenue and Growth (2012-2017)
Figure Mexico Overactive Bladder Treatment Sales and Growth (2012-2017)
Table Mexico Overactive Bladder Treatment Sales by Type (2012-2017)
Table Mexico Overactive Bladder Treatment Sales Market Share by Type (2012-2017)
Table Mexico Overactive Bladder Treatment Sales by Application (2012-2017)
Table Mexico Overactive Bladder Treatment Sales Market Share by Application (2012-2017)
Table Mexico Overactive Bladder Treatment Sales by Manufacturer (2016-2017)
Figure Mexico Overactive Bladder Treatment Sales Market Share by Manufacturer in 2016
Figure Mexico Overactive Bladder Treatment Sales Market Share by Manufacturer in 2017
Table Mexico Overactive Bladder Treatment Revenue by Manufacturer (2016-2017)
Figure Mexico Overactive Bladder Treatment Revenue Market Share by Manufacturer in 2016
Figure Mexico Overactive Bladder Treatment Revenue Market Share by Manufacturer in 2017
Table Mexico Overactive Bladder Treatment Export and Import (2012-2017)
Figure North America Overactive Bladder Treatment Sales, Revenue and Growth Rate (2017-2022)
Table North America Overactive Bladder Treatment Sales Forecast by Countries (2017-2022)
Table North America Overactive Bladder Treatment Market Share Forecast by Countries (2017-2022)
Figure United States Overactive Bladder Treatment Sales Forecast (2017-2022)
Figure Canada Overactive Bladder Treatment Sales Forecast (2017-2022)
Figure Mexico Overactive Bladder Treatment Sales Forecast (2017-2022)
Table North America Overactive Bladder Treatment Sales Forecast by Type (2017-2022)
Table North America Overactive Bladder Treatment Market Share Forecast by Type (2017-2022)
Table North America Overactive Bladder Treatment Sales Forecast by Application (2017-2022)
Table North America Overactive Bladder Treatment Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Overactive Bladder Treatment
Figure Manufacturing Process Analysis of Overactive Bladder Treatment
Figure Overactive Bladder Treatment Industrial Chain Analysis
Table Raw Materials Sources of Overactive Bladder Treatment Major Manufacturers in 2016
Table Major Buyers of Overactive Bladder Treatment
Table Distributors/Traders/ Dealers List 

Let our analyst help you with a customized solution for your market research needs